GoodRx Inc. (GDRX)
NASDAQ: GDRX
· Real-Time Price · USD
4.53
0.04 (0.78%)
At close: Oct 03, 2025, 3:59 PM
4.58
1.10%
After-hours: Oct 03, 2025, 07:58 PM EDT
GoodRx Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Revenue Revenue | 4.56M | 4.38M | 10.24M | 5.39M | 5.41M | 5.38M | 5.23M | 5.39M | 4.93M | 4.5M | 5.17M | 5.15M | 4.86M | 5.24M | 37.09M | 23.22M | 17.46M | 26.37M | 22.24M | 16.07M |
| Other Revenue Revenue Growth | +4.11% | -57.19% | +89.93% | -0.28% | +0.56% | +2.81% | -3.08% | +9.43% | +9.51% | -12.96% | +0.35% | +6.05% | -7.32% | -85.86% | +59.71% | +33.00% | -33.78% | +18.59% | +38.39% | n/a |
| Prescription Transactions Revenue Revenue | 143.06M | 148.92M | 291.74M | 140.42M | 146.75M | 145.4M | 143.86M | 135.43M | 136.54M | 134.91M | 129.41M | 131.22M | 134.4M | 155.51M | 158.79M | 155.65M | 144.86M | 134.06M | 131.31M | 124.39M |
| Prescription Transactions Revenue Revenue Growth | -3.93% | -48.95% | +107.76% | -4.31% | +0.93% | +1.06% | +6.23% | -0.82% | +1.21% | +4.25% | -1.38% | -2.37% | -13.57% | -2.07% | +2.02% | +7.45% | +8.05% | +2.10% | +5.56% | n/a |
| Subscription Revenue Revenue | 20.46M | 21.02M | 42.63M | 21.31M | 21.95M | 22.6M | 23.15M | 23.24M | 23.88M | 24.14M | 24.62M | 26.45M | 25.98M | 19.11M | 17.38M | 16.23M | 14.32M | n/a | n/a | n/a |
| Subscription Revenue Revenue Growth | -2.64% | -50.70% | +100.08% | -2.95% | -2.87% | -2.37% | -0.39% | -2.67% | -1.10% | -1.95% | -6.91% | +1.79% | +35.98% | +9.98% | +7.09% | +13.34% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 112.35M | 114.17M | 117.38M | 115.49M | 120.3M | 131.07M | 123.06M | 126.93M | 107.65M | 108.14M | 112.71M | 135.76M | 129.08M | 124.87M | 141.87M | 131.6M | 127.96M | 123.48M | 415.69M | 173.59M | 58.25M | 69.05M | 58.85M | 49.05M | 41.2M | 41.39M |
| Selling, General, and Administrative Revenue Growth | -1.60% | -2.73% | +1.64% | -4.00% | -8.22% | +6.51% | -3.05% | +17.91% | -0.46% | -4.05% | -16.98% | +5.18% | +3.37% | -11.98% | +7.80% | +2.84% | +3.63% | -70.30% | +139.47% | +198.00% | -15.64% | +17.32% | +19.98% | +19.06% | -0.45% | n/a |
| Research and Development Revenue | 29.93M | 31.14M | 31.74M | 30.14M | 30.85M | 31.02M | 31.53M | 39.61M | 31.29M | 32.91M | 36.77M | 35.92M | 35.4M | 35.04M | 35.06M | 35.07M | 29.57M | 26.16M | 23.68M | 15.85M | 11.96M | 10.32M | 9.82M | 7.84M | 6M | 5.82M |
| Research and Development Revenue Growth | -3.88% | -1.88% | +5.31% | -2.32% | -0.53% | -1.63% | -20.40% | +26.61% | -4.93% | -10.50% | +2.36% | +1.46% | +1.03% | -0.05% | -0.04% | +18.62% | +13.02% | +10.46% | +49.46% | +32.47% | +15.85% | +5.14% | +25.19% | +30.80% | +3.08% | n/a |
| Sales and Marketing Revenue | 84.87M | 84.54M | 93.83M | 89.87M | 93.45M | 89.96M | 93.75M | 91.61M | 80.46M | 78.52M | 84.13M | 86.22M | 94.34M | 92.95M | 106.49M | 95.65M | 88.38M | 79.69M | 74.94M | 65.11M | 51.92M | 63.16M | 54.33M | 44.95M | 37.77M | 38.84M |
| Sales and Marketing Revenue Growth | +0.39% | -9.90% | +4.41% | -3.84% | +3.88% | -4.04% | +2.33% | +13.86% | +2.47% | -6.66% | -2.42% | -8.61% | +1.49% | -12.72% | +11.33% | +8.23% | +10.90% | +6.34% | +15.09% | +25.41% | -17.80% | +16.26% | +20.86% | +19.02% | -2.78% | n/a |